NCT05590858View on ClinicalTrials.gov

Glycemic Control on Coronary Inflammation Evaluated by FAI in ACS

CompletedOBSERVATIONAL
Enrollment

309

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

December 31, 2020

Study Completion Date

October 1, 2022

Conditions
Inflammation Vascular
Trial Locations (1)

200127

Cardiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

All Listed Sponsors
lead

RenJi Hospital

OTHER

NCT05590858 - Glycemic Control on Coronary Inflammation Evaluated by FAI in ACS | Biotech Hunter | Biotech Hunter